Progression
·MeSH: Disease Progression
26 drugs in development·11 companies·1 clinical trial
Drug Pipeline by Phase
Approved(6)
| Drug | Company |
|---|---|
| FILSPARI® | Travere Therapeutics, Inc. (TVTX) |
| Jardiance | ELI LILLY & Co (LLY) |
| Jardiance® | ELI LILLY & Co (LLY) |
| SKYSONA | bluebird bio, Inc. (BLUE) |
| Sotrovimab | Xencor Inc (XNCR) |
| Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco) | Merus N.V. (MRUS) |
Phase 3(4)
Phase 2(12)
Preclinical(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Progression?
BioSniper tracks 26 drugs in development for Progression across 11 companies.
How many clinical trials target Progression?
There are 1 clinical trial targeting Progression tracked by BioSniper.
Analyze Travere Therapeutics, Inc.'s Progression pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company